The manufacturers of Zantac, a heartburn drug with the generic name ranitidine, are facing lawsuits from former patients who developed cancer after taking the medication. Plaintiffs allege that that the drug’s manufacturers failed to warn patients of the presence of N-Nitrosodimethylamine (NDMA), a potential carcinogen, in certain batches of Zantac.
If you developed cancer after taking Zantac, you may be eligible for this litigation — and Shapiro Legal Group, PLLC can help. We represent clients nationwide in their fight to seek just compensation from manufacturers of dangerous and defective drugs. Contact us online or call anytime – it never will cost you to find out if you have a case. (800) 220-0984
How Our Zantac Lawyers Can Help
- Our attorneys hold over 20 years of experience representing injured plaintiffs, specializing in dangerous and defective drug lawsuits.
- Our results speak for themselves. We have helped thousands of people across the country secure the compensation they deserve, including California residents.
- We understand how difficult cancer treatment can be. That’s why we handle each aspect of your claim from start to finish, allowing you to focus on your recovery.
Criteria for Zantac Litigation
Zantac litigation has recently been revived in state court. Criteria for ongoing litigation includes the following:
- Use of over-the-counter Zantac for a minimum of 1 year (Prescription Zantac
not accepted) - Diagnosed with Cancer at LEAST 1 year after Zantac usage start date.
- Usage of Zantac must start after 2006.
- Diagnosed with cancer within the past 5 years
Qualifying cancers
- Bladder
- Esophageal
- Gastric
- Intestinal
- Liver (no Hep B or Hep C dx)
- Pancreatic
- Stomach
- Lung (non smoker for at least 10 years)
- Colon
What We Know About Zantac’s Link to Cancer
In September 2019, the U.S. Food and Drug Administration (FDA) announced that it was launching an investigation after NDMA, a carcinogenic chemical, was found in certain batches of Zantac.
Valisure, an online pharmacy based in Connecticut, brought the issue to the agency’s attention. Research shows that NDMA may cause cancer in humans; scientists use this chemical to induce cancer in laboratory rats in clinical studies.
In April 2020, the FDA requested that manufacturers remove all prescription and over-the-counter ranitidine products due to the presence of NDMA. Now, patients are filing claims to seek damages for the losses they endured due to their cancer diagnoses.
What Cancers Are Linked to Zantac?
If you developed cancer after taking Zantac, you may be eligible for financial compensation through a lawsuit in California civil court. With this legal pathway, you can collect funds for multiple losses related to your cancer, including past and future medical treatment, lost wages, and physical and emotional pain and suffering.
Former Zantac patients report developing a wide variety of cancers after taking the medication, which include but are not limited to the following.
- Bladder cancer
- Ovarian cancer
- Stomach cancer
- Prostate cancer
- Kidney cancer
- Esophageal cancer
- Melanoma
- Bladder cancer
- Breast cancer
- Colon cancer
In some cases, patients had to undergo a bladder or kidney removal after taking Zantac. In addition, some patients report receiving a diagnosis for Crohn’s disease or primary pulmonary hypertension (PPH) along with their cancer diagnosis. Zantac might contribute to these conditions as well.
The above list is not exhaustive, and attorneys are accepting claims for patients who have developed multiple types of cancer. To determine if you have grounds for a Zantac lawsuit, speak to a lawyer at Shapiro Legal Group, PLLC.
Contact Shapiro Legal Group, PLLC
If you are a former Zantac patient who developed cancer after taking the medication, you may qualify for legal action. Shapiro Legal Group, PLLC represents California Zantac patients in their fight to secure the compensation they need to recover.
Contact us today to schedule your free consultation with our Zantac injury lawyers. We respond to all consultation requests within 24 hours of receipt.